Catalyst Wire Dossier Catalyst Wire Dossier

99mTc-MIP-1404

Technetium-99m MIP-1404 · Molecular Insight Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for 99mTc-MIP-1404, covering 2015-11-25 to 2019-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer [Phase 3]

See pricing